These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 427687)

  • 21. [Porphyria cutanea tarda].
    Velde KT; Noordhoek KH
    Ned Tijdschr Geneeskd; 1976 May; 120(22):952-7. PubMed ID: 1272435
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)].
    Leonhardi G; Klähn KH; Gürenci J
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):43-6. PubMed ID: 401939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 24. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.
    Percy VA; Naidoo D; Joubert SM; Pegoraro RJ
    S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phlebotomy and iron-overload in porphyria cutanea tarda.
    Kalivas JT; Pathak MA; Fitzpatrick TB
    Lancet; 1969 Jun; 1(7607):1184-7. PubMed ID: 4181840
    [No Abstract]   [Full Text] [Related]  

  • 27. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute and cutaneous porphyrias.
    Badminton MN; Elder GH
    Int J Clin Pract; 2002 May; 56(4):272-8. PubMed ID: 12074210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic aspects of porphyria cutanea tarda.
    Lambrecht RW; Thapar M; Bonkovsky HL
    Semin Liver Dis; 2007 Feb; 27(1):99-108. PubMed ID: 17295179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients.
    Grossman ME; Bickers DR; Poh-Fitzpatrick MB; Deleo VA; Harber LC
    Am J Med; 1979 Aug; 67(2):277-86. PubMed ID: 463934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.
    Malina L; Chlumský J; Chlumská A
    Acta Univ Carol Med Monogr; 1974; (59):1-126. PubMed ID: 4616623
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis].
    Wolff C; Armas R; Krause P; Parraguez A; Ramón Soto J
    Rev Med Chil; 1996 Apr; 124(4):456-60. PubMed ID: 9110486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron metabolism in porphyria cutanea tarda.
    Reizenstein P; Höglund S; Landegren J; Carlmark B; Forsberg K
    Acta Med Scand; 1975; 198(1-2):95-9. PubMed ID: 1166830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron and porphyria cutanea tarda.
    D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
    Kushner JP; Steinmuller DP; Lee GR
    J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.